A5071597562- HIV/AIDS Research and Interventions
- HIV Research and Treatment
- SARS-CoV-2 and COVID-19 Research
- HIV, Drug Use, Sexual Risk
- COVID-19 Clinical Research Studies
- COVID-19 Impact on Reproduction
- COVID-19 diagnosis using AI
- COVID-19 epidemiological studies
- HIV/AIDS drug development and treatment
- Advanced MRI Techniques and Applications
- Cell Image Analysis Techniques
- Tuberculosis Research and Epidemiology
- Bacterial Identification and Susceptibility Testing
- Functional Brain Connectivity Studies
Centers for Disease Control and Prevention
2022-2024
Center for Global Health
2022-2024
Centers for Disease Control and Prevention
2022-2024
AID Atlanta
2024
Georgia Institute of Technology
2019
Diagnosis of tuberculosis (TB) among young children (<5 years) is challenging due to the paucibacillary nature clinical disease and similarities other childhood diseases. We used machine learning develop accurate prediction models microbial confirmation with simply defined easily obtainable clinical, demographic, radiologic factors. evaluated eleven supervised (using stepwise regression, regularized decision tree, support vector approaches) predict in using samples from invasive...
Background: To inform optimal management of HIV viremia on tenofovir, lamivudine, and dolutegravir (TLD), we examined viral load (VL) outcomes a large cohort adult PWH TLD in Nigeria. Methods: We conducted retrospective study who had ≥1 VL after initiating during January 2017–February 2023. VLs were categorized as undetectable (≤50 copies/ml), low low-level (LLV, 51–199 high LLV (200–999 virologic nonsuppression (VLNS, ≥1000 failure (VF, ≥2 consecutive VLNS results). Among patients with TLD,...
As antiretroviral treatment (ART) coverage for people living with HIV (PLHIV) increases, programmes require up-to-date information about evolving risk behaviour and transmission risk, including those low-level viremia (LLV; >50 to ≤1000 copies/mL), guide prevention priorities. We aimed assess differences in sexual behaviours, distribution of viral load (VL) proportion across PLHIV subgroups. analysed data from Population-based Impact Assessment surveys 14 sub-Saharan African countries...
The burden of SARS-CoV-2 infection in people living with HIV (PLHIV) South Sudan is unknown.
Background: Virologic suppression (VS) has been defined using an HIV viral load (VL) of <1,000 copies/mL. Low-level viremia (51-999 copies/mL) is associated with increased risk virologic failure and drug resistance. Methods: Retrospective data from persons (PWH) who initiated ART between January 2016–September 2022 in Nigeria were analyzed for VS at cut-off values <1000 Results: In 2022, copies/mL was 95.7%. Using <400, <200 <50 copies/mL, 94.2%, 92.5%, 87.0%, respectively....
Background: HIV transmission can occur with viral load (VL) ≥200 copies/mL and low-level viremia (LLV) lead to virologic failure; the level at which risk for failure is conferred uncertain. To better understand LLV prevalence outcomes, we analyzed retrospective longitudinal data from a large cohort of people living (PLHIV) on ART in Nigeria.Methods: We estimated rates suppression (≤50 copies/mL), (51–999 non-suppression (≥1,000 (≥2 consecutive results) among PLHIV ≥18 years who initiated...